ANAB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.02

Margin Of Safety %

-20

Put/Call OI Ratio

0.98

EPS Next Q Diff

2.22

EPS Last/This Y

0.23

EPS This/Next Y

5.47

Price

56.62

Target Price

81.5

Analyst Recom

1.12

Performance Q

-15.46

Upside

-166.8%

Beta

0.86

Ticker: ANAB

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	ANAB	69.66	1.11	0.04	2146
2026-07-14	ANAB	62.35	1.01	2.69	2248
2026-07-15	ANAB	55.88	1.06	2.56	2374
2026-07-16	ANAB	54.09	1.30	6.14	2990
2026-07-17	ANAB	57.96	1.25	0.10	2933
2026-07-20	ANAB	50.27	1.28	0.98	1905
2026-07-21	ANAB	53.75	1.05	1.12	7972
2026-07-22	ANAB	52.52	1.06	2.83	8345
2026-07-23	ANAB	54.96	1.06	3.47	8356
2026-07-24	ANAB	54.12	1.03	0.03	8354
2026-07-27	ANAB	53.63	1.01	6.91	8438
2026-07-28	ANAB	52.07	1.02	0.36	8477
2026-07-29	ANAB	52.11	1.02	0.71	8470
2026-07-30	ANAB	54.98	1.01	0.00	8576
2026-07-31	ANAB	53.39	0.99	0.67	8644
2026-08-03	ANAB	53.62	0.99	4.67	8649
2026-08-04	ANAB	55.17	0.99	4.67	8649
2026-08-05	ANAB	54.89	0.99	2.33	8652
2026-08-07	ANAB	56.65	0.98	0.00	8696
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	ANAB	69.71	110.6	-59.2	-0.23
2026-07-14	ANAB	62.44	110.6	-58.7	-0.23
2026-07-15	ANAB	55.82	110.6	-58.7	-0.23
2026-07-16	ANAB	54.13	110.6	-59.0	-0.23
2026-07-17	ANAB	58.04	110.6	-59.3	-0.23
2026-07-20	ANAB	50.29	110.6	-58.6	-0.23
2026-07-21	ANAB	53.76	110.6	-59.3	-0.23
2026-07-22	ANAB	52.67	110.6	-59.0	-0.23
2026-07-23	ANAB	54.97	110.6	-59.2	-0.23
2026-07-24	ANAB	54.12	110.6	-59.0	-0.23
2026-07-27	ANAB	53.65	110.6	-59.0	-0.23
2026-07-28	ANAB	52.04	110.6	-58.9	-0.23
2026-07-29	ANAB	52.16	110.6	-59.1	-0.23
2026-07-30	ANAB	54.96	110.6	-59.3	-0.23
2026-07-31	ANAB	53.28	110.6	-58.9	-0.23
2026-08-03	ANAB	53.69	110.6	-59.1	-0.23
2026-08-04	ANAB	53.69	110.6	-59.1	-0.23
2026-08-05	ANAB	54.97	110.6	-59.1	-0.23
2026-08-06	ANAB	54.79	110.6	-59.0	-0.23
2026-08-07	ANAB	56.62	110.6	-59.2	-0.23
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	ANAB	-3.10	2.34	18.55
2026-07-14	ANAB	-3.10	2.34	18.55
2026-07-15	ANAB	-3.10	2.34	18.55
2026-07-16	ANAB	-3.10	2.34	18.55
2026-07-17	ANAB	-2.54	2.34	18.55
2026-07-20	ANAB	-2.54	2.44	18.55
2026-07-21	ANAB	-2.54	2.44	18.55
2026-07-22	ANAB	-2.54	2.44	18.55
2026-07-23	ANAB	-2.54	2.44	18.55
2026-07-24	ANAB	-2.54	2.44	18.55
2026-07-27	ANAB	-2.54	0.29	18.02
2026-07-28	ANAB	-2.54	0.29	18.02
2026-07-29	ANAB	-2.54	0.29	18.02
2026-07-30	ANAB	-2.54	0.29	18.02
2026-07-31	ANAB	-2.54	0.29	18.02
2026-08-03	ANAB	-2.54	0.61	18.02
2026-08-04	ANAB	-2.54	0.61	18.02
2026-08-05	ANAB	-2.54	0.61	18.02
2026-08-06	ANAB	-2.54	0.61	18.02
2026-08-07	ANAB	-2.54	0.61	18.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.84

Avg. EPS Est. Current Quarter

0.14

Avg. EPS Est. Next Quarter

0.38

Insider Transactions

-2.54

Institutional Transactions

0.61

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

45.11

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.8

Max Drawdown 5-Year %

-69.3

Target Price

81.5

P/E

Forward P/E

28.95

PEG

P/S

7.21

P/B

128.93

P/Free Cash Flow

380.08

EPS

-1.08

Average EPS Est. Cur. Y

-0.23

EPS Next Y. (Est.)

5.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.53

Relative Volume

0.82

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-59.2

◆ ANAB Healthcare

$56.61

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

13/25

Volume

7/15

Valuation

12/20

TP/AR

4/10

Options

5/10

RSI

50.6

Range 1M

30.9%

Sup Dist

5.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

10/30

Estimates

6/20

Inst/Vol

4/15

Options

3/10

EPS Yr

-393.4%

EPS NY

229.3%

52W%

73.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +114.7% upside

Quality

9/30

Valuation

17/30

Growth

7/25

Stability

6/10

LT Trend

3/5

Upside

+114.7%

Quality

MoS

-20%

ANAB — P/E HistoricalBiotechnology

AnaptysBio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 104

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

ANAB

Latest News

—

Caricamento notizie per ANAB…

stock quote shares ANAB – AnaptysBio Inc Stock Price stock today

news today ANAB – AnaptysBio Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANAB – AnaptysBio Inc yahoo finance google finance

stock history ANAB – AnaptysBio Inc invest stock market

stock prices ANAB premarket after hours

ticker ANAB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ANAB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y